Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation.

Standard

Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation. / Kluge, Stefan; Baumann, Hans Jörg; Regelsberger, Jan; Kehler, Uwe; Koziej, Barbara; Klose, Hans; Greinert, Ulf; Kreymann, Karl-Georg; Meyer, Andreas.

In: RESPIRATION, Vol. 78, No. 1, 1, 2009, p. 30-35.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Kluge, S, Baumann, HJ, Regelsberger, J, Kehler, U, Koziej, B, Klose, H, Greinert, U, Kreymann, K-G & Meyer, A 2009, 'Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation.', RESPIRATION, vol. 78, no. 1, 1, pp. 30-35. <http://www.ncbi.nlm.nih.gov/pubmed/18799867?dopt=Citation>

APA

Kluge, S., Baumann, H. J., Regelsberger, J., Kehler, U., Koziej, B., Klose, H., Greinert, U., Kreymann, K-G., & Meyer, A. (2009). Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation. RESPIRATION, 78(1), 30-35. [1]. http://www.ncbi.nlm.nih.gov/pubmed/18799867?dopt=Citation

Vancouver

Kluge S, Baumann HJ, Regelsberger J, Kehler U, Koziej B, Klose H et al. Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation. RESPIRATION. 2009;78(1):30-35. 1.

Bibtex

@article{59cee1a2372d4d46913a75d0a4ddfd9e,
title = "Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation.",
abstract = "BACKGROUND: The insertion of ventriculoatrial (VA) shunts for the treatment of hydrocephalus is thought to be associated with the development of pulmonary hypertension in adults. OBJECTIVES: It was the aim of this study to describe the frequency and the clinical spectrum of pulmonary hypertension in adults with VA shunts. METHODS: Patients with pulmonary hypertension were retrospectively evaluated from January 1999 to December 2006. RESULTS: Among the 575 patients with pulmonary hypertension, 6 (mean age 42.5 +/- 8.3 years) were identified as having received a VA shunt. Mean pulmonary artery pressure for these patients was 53.3 +/- 14.9 mm Hg. The interval between shunt placement and the diagnosis of pulmonary hypertension was 9-27 years (median 16.5). While ventilation perfusion scans showed multiple bilateral perfusion defects in all patients, chest CT or pulmonary angiography demonstrated pulmonary thromboembolism in only 2 of the 6 patients. These 2 patients subsequently underwent pulmonary endarterectomy. Another patient required heart-lung transplantation because of severe pulmonary hypertension; lung histology showed prominent eccentric medial hypertrophy and intimal proliferation without evidence of thromboembolism. Contrary to earlier reports, outcomes were generally good, with a 100% survival rate for the first 8 years following diagnosis. CONCLUSIONS: Severe pulmonary hypertension can develop in adult patients with VA shunts. Therefore, clinicians should consider pulmonary hypertension as a potential cause for respiratory symptoms in patients who have received VA shunts.",
author = "Stefan Kluge and Baumann, {Hans J{\"o}rg} and Jan Regelsberger and Uwe Kehler and Barbara Koziej and Hans Klose and Ulf Greinert and Karl-Georg Kreymann and Andreas Meyer",
year = "2009",
language = "Deutsch",
volume = "78",
pages = "30--35",
journal = "RESPIRATION",
issn = "0025-7931",
publisher = "S. Karger AG",
number = "1",

}

RIS

TY - JOUR

T1 - Development of pulmonary hypertension in adults after ventriculoatrial shunt implantation.

AU - Kluge, Stefan

AU - Baumann, Hans Jörg

AU - Regelsberger, Jan

AU - Kehler, Uwe

AU - Koziej, Barbara

AU - Klose, Hans

AU - Greinert, Ulf

AU - Kreymann, Karl-Georg

AU - Meyer, Andreas

PY - 2009

Y1 - 2009

N2 - BACKGROUND: The insertion of ventriculoatrial (VA) shunts for the treatment of hydrocephalus is thought to be associated with the development of pulmonary hypertension in adults. OBJECTIVES: It was the aim of this study to describe the frequency and the clinical spectrum of pulmonary hypertension in adults with VA shunts. METHODS: Patients with pulmonary hypertension were retrospectively evaluated from January 1999 to December 2006. RESULTS: Among the 575 patients with pulmonary hypertension, 6 (mean age 42.5 +/- 8.3 years) were identified as having received a VA shunt. Mean pulmonary artery pressure for these patients was 53.3 +/- 14.9 mm Hg. The interval between shunt placement and the diagnosis of pulmonary hypertension was 9-27 years (median 16.5). While ventilation perfusion scans showed multiple bilateral perfusion defects in all patients, chest CT or pulmonary angiography demonstrated pulmonary thromboembolism in only 2 of the 6 patients. These 2 patients subsequently underwent pulmonary endarterectomy. Another patient required heart-lung transplantation because of severe pulmonary hypertension; lung histology showed prominent eccentric medial hypertrophy and intimal proliferation without evidence of thromboembolism. Contrary to earlier reports, outcomes were generally good, with a 100% survival rate for the first 8 years following diagnosis. CONCLUSIONS: Severe pulmonary hypertension can develop in adult patients with VA shunts. Therefore, clinicians should consider pulmonary hypertension as a potential cause for respiratory symptoms in patients who have received VA shunts.

AB - BACKGROUND: The insertion of ventriculoatrial (VA) shunts for the treatment of hydrocephalus is thought to be associated with the development of pulmonary hypertension in adults. OBJECTIVES: It was the aim of this study to describe the frequency and the clinical spectrum of pulmonary hypertension in adults with VA shunts. METHODS: Patients with pulmonary hypertension were retrospectively evaluated from January 1999 to December 2006. RESULTS: Among the 575 patients with pulmonary hypertension, 6 (mean age 42.5 +/- 8.3 years) were identified as having received a VA shunt. Mean pulmonary artery pressure for these patients was 53.3 +/- 14.9 mm Hg. The interval between shunt placement and the diagnosis of pulmonary hypertension was 9-27 years (median 16.5). While ventilation perfusion scans showed multiple bilateral perfusion defects in all patients, chest CT or pulmonary angiography demonstrated pulmonary thromboembolism in only 2 of the 6 patients. These 2 patients subsequently underwent pulmonary endarterectomy. Another patient required heart-lung transplantation because of severe pulmonary hypertension; lung histology showed prominent eccentric medial hypertrophy and intimal proliferation without evidence of thromboembolism. Contrary to earlier reports, outcomes were generally good, with a 100% survival rate for the first 8 years following diagnosis. CONCLUSIONS: Severe pulmonary hypertension can develop in adult patients with VA shunts. Therefore, clinicians should consider pulmonary hypertension as a potential cause for respiratory symptoms in patients who have received VA shunts.

M3 - SCORING: Zeitschriftenaufsatz

VL - 78

SP - 30

EP - 35

JO - RESPIRATION

JF - RESPIRATION

SN - 0025-7931

IS - 1

M1 - 1

ER -